Northrop to upgrade US Army’s Joint Tactical Ground Station

22 October 2012 (Last Updated October 22nd, 2012 03:40)

Northrop Grumman has been awarded a pre-planned product improvement (P3I) contract for modernisation of the US Army's Joint Tactical Ground Station (JTAGS) systems.

Northrop Grumman has been awarded a pre-planned product improvement (P3I) contract for modernisation of the US Army's Joint Tactical Ground Station (JTAGS) systems.

Valued at $31.5m, the award covers initial development, testing, certification and fielding of P3I upgrades to JTAGS, with an aim to help enhance troops' missile warning capability in the battlefield.

"The enhanced JTAGS system will provide improved detection and reporting of theater ballistic missiles and improved missile defense and situational awareness capabilities anywhere in the world."

The contract also includes multiple options for further production and sustainment efforts that are scheduled to continue until 2022.

Northrop Grumman C4ISR Networked Systems business unit vice president Ed Bush said the company had partnered the army to support this critical mission due to its long-standing relationship with the JTAGS programme.

"The enhanced JTAGS system will provide improved detection and reporting of theater ballistic missiles and improved missile defense and situational awareness capabilities anywhere in the world," Bush added.

The JTAGS is a relocatable, information processing system designed to broadcast warning, alerting and cueing information on tactical ballistic missiles (TBMs) and other events of interest to deployed commanders.

Using the integrated broadcast service (IBS) and link 16, the JTAGS obtains and processes overhead non-imaging infrared (ONIR) data that is directly down-linked from defence support programme (DSP) space-based infrared and other satellite sensors to issue TBM threat warning for protection of military assets, civilian populations and geopolitical centres.

Work under the contract is scheduled to be carried out at the company's facilities in Colorado Springs in Colorado and Azusa in California, US.